"massaged into just what the EMA wants to see". And we were right in the middle of that time period. Asked to File for Full Approval Dec 23 rapporteurs appointed I think it was in Jan or Feb 2024. So they asked we answered and the filing was accepted late Dec 2024. We will have all the OLE compiled and will present soon at some conference. And am sure they will have also sent all off to the rapporteurs. From the leaks we already know the OLE is good. Some up to 4 years and some up to NINE YEARS on 2-73. 74 still remain on the drug. Our efficacy is better than any of the MAB's We don't have any safety issues. What little bit we had has been fixed by slower Titration. Plus give patients the pill before bedtime. Very little dizziness.
A little bit about someone else. Good friend of my Brother... his wife was in the Biogen Trial. Included the stop during covid. Then the restart. Then came the day they said you can't have any more of the drug. She had of course continued to go downhill during but not as fast as a normal only on SOC drug. Well as soon as she was off the drug it was a rapid drop. She can't remember her husbands name. At least she never had the brain bleed.
Last bit for this evening. Today a total of 677,000 shares traded. 78,000 of them traded as MOC order. Easy for whoever is getting the shares 1/2Million a week. All we know is 4th qtr 2024 we went from 31% to 42% tute ownership. Now half way through Q1 2025 and we won't know what happened until May 15th.
John k9uwa
Bullish
Market Data 
Markets 
AI
